206 related articles for article (PubMed ID: 7542140)
1. Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.
Ding J; Das K; Tantillo C; Zhang W; Clark AD; Jessen S; Lu X; Hsiou Y; Jacobo-Molina A; Andries K
Structure; 1995 Apr; 3(4):365-79. PubMed ID: 7542140
[TBL] [Abstract][Full Text] [Related]
2. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E
J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966
[TBL] [Abstract][Full Text] [Related]
3. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.
Hsiou Y; Ding J; Das K; Clark AD; Boyer PL; Lewi P; Janssen PA; Kleim JP; Rösner M; Hughes SH; Arnold E
J Mol Biol; 2001 Jun; 309(2):437-45. PubMed ID: 11371163
[TBL] [Abstract][Full Text] [Related]
4. Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors.
Ding J; Das K; Moereels H; Koymans L; Andries K; Janssen PA; Hughes SH; Arnold E
Nat Struct Biol; 1995 May; 2(5):407-15. PubMed ID: 7545077
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.
Das K; Ding J; Hsiou Y; Clark AD; Moereels H; Koymans L; Andries K; Pauwels R; Janssen PA; Boyer PL; Clark P; Smith RH; Kroeger Smith MB; Michejda CJ; Hughes SH; Arnold E
J Mol Biol; 1996 Dec; 264(5):1085-100. PubMed ID: 9000632
[TBL] [Abstract][Full Text] [Related]
6. 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains).
Unge T; Knight S; Bhikhabhai R; Lövgren S; Dauter Z; Wilson K; Strandberg B
Structure; 1994 Oct; 2(10):953-61. PubMed ID: 7532533
[TBL] [Abstract][Full Text] [Related]
7. Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.
Shen L; Shen J; Luo X; Cheng F; Xu Y; Chen K; Arnold E; Ding J; Jiang H
Biophys J; 2003 Jun; 84(6):3547-63. PubMed ID: 12770866
[TBL] [Abstract][Full Text] [Related]
8. Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)] (TSAO) derivatives is determined by the mutation Glu138-->Lys on the p51 subunit.
Jonckheere H; Taymans JM; Balzarini J; Velázquez S; Camarasa MJ; Desmyter J; De Clercq E; Anné J
J Biol Chem; 1994 Oct; 269(41):25255-8. PubMed ID: 7523383
[TBL] [Abstract][Full Text] [Related]
9. Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function.
Bahar I; Erman B; Jernigan RL; Atilgan AR; Covell DG
J Mol Biol; 1999 Jan; 285(3):1023-37. PubMed ID: 9887265
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity.
Kroeger Smith MB; Rouzer CA; Taneyhill LA; Smith NA; Hughes SH; Boyer PL; Janssen PA; Moereels H; Koymans L; Arnold E
Protein Sci; 1995 Oct; 4(10):2203-22. PubMed ID: 8535257
[TBL] [Abstract][Full Text] [Related]
11. High resolution structures of HIV-1 RT from four RT-inhibitor complexes.
Ren J; Esnouf R; Garman E; Somers D; Ross C; Kirby I; Keeling J; Darby G; Jones Y; Stuart D
Nat Struct Biol; 1995 Apr; 2(4):293-302. PubMed ID: 7540934
[TBL] [Abstract][Full Text] [Related]
12. Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.
Hsiou Y; Das K; Ding J; Clark AD; Kleim JP; Rösner M; Winkler I; Riess G; Hughes SH; Arnold E
J Mol Biol; 1998 Nov; 284(2):313-23. PubMed ID: 9813120
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.
Esnouf R; Ren J; Ross C; Jones Y; Stammers D; Stuart D
Nat Struct Biol; 1995 Apr; 2(4):303-8. PubMed ID: 7540935
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.
Jacobo-Molina A; Ding J; Nanni RG; Clark AD; Lu X; Tantillo C; Williams RL; Kamer G; Ferris AL; Clark P
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6320-4. PubMed ID: 7687065
[TBL] [Abstract][Full Text] [Related]
15. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
Smerdon SJ; Jäger J; Wang J; Kohlstaedt LA; Chirino AJ; Friedman JM; Rice PA; Steitz TA
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3911-5. PubMed ID: 7513427
[TBL] [Abstract][Full Text] [Related]
16. Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations.
Arnold E; Jacobo-Molina A; Nanni RG; Williams RL; Lu X; Ding J; Clark AD; Zhang A; Ferris AL; Clark P
Nature; 1992 May; 357(6373):85-9. PubMed ID: 1374166
[TBL] [Abstract][Full Text] [Related]
17. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.
Ren J; Nichols C; Bird L; Chamberlain P; Weaver K; Short S; Stuart DI; Stammers DK
J Mol Biol; 2001 Sep; 312(4):795-805. PubMed ID: 11575933
[TBL] [Abstract][Full Text] [Related]
18. Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.
Boyer PL; Ding J; Arnold E; Hughes SH
Antimicrob Agents Chemother; 1994 Sep; 38(9):1909-14. PubMed ID: 7529011
[TBL] [Abstract][Full Text] [Related]
19. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E
J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729
[TBL] [Abstract][Full Text] [Related]
20. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers DW; Gamblin SJ; Harris BA; Ray S; Culp JS; Hellmig B; Woolf DJ; Debouck C; Harrison SC
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1222-6. PubMed ID: 7532306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]